Fundraising Fox

CerSci Therapeutics

Dallas, US · Founded 2019 · Delaware corporation

Founders & leadership

PM
Perry MolinoffNamed on SEC filing
JD
John D. Harkey, Jr.Named on SEC filing
BD
Brent DuncanNamed on SEC filing
PC
Pat ConfaloneNamed on SEC filing
DR
Dennis RobbinsNamed on SEC filing
DH
David Hitt IINamed on SEC filing
DG
David GenecovNamed on SEC filing
SD
Scott DaxNamed on SEC filing
TB
Tyler BrousNamed on SEC filing
LR
Lucas RodriguezNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$12M disclosed across 1 round · 2019

$12MraisedMar 2020 · 24 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Perry MolinoffDirector
  • John D. Harkey, Jr.Director
  • Brent DuncanDirector
  • Pat ConfaloneDirector
  • Dennis RobbinsDirector
  • David Hitt IIDirector
  • David GenecovDirector
  • Scott DaxDirector
  • Tyler BrousDirector
  • Lucas RodriguezExecutive Officer, Director
Offering amount
$12M
Amount sold
$12M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$221.8K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$225K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

How much funding has CerSci Therapeutics raised?
CerSci Therapeutics has disclosed $12M raised across 1 round.
Where is CerSci Therapeutics headquartered?
CerSci Therapeutics is headquartered in Dallas, US.